Pharmaceuticals, Biotechnology and Life Sciences
OptiBiotix Health, a life sciences business developing compounds to tackle obesity, highcholesterol, diabetes and skin care, has appointed Christina Wood as Sales and Marketing Director.
Galapagos has appointed Dr. Walid Abi-Saab as a Chief Medical Officer (CMO), who came from Shire Pharmaceuticals, beginning on March 1, 2017.
Zealand Pharma has announced a $10 million milestone payment following Sanofi’s announcement of European Commission marketing authorization in Europe for…
Motif Bio, the clinical stage biopharmaceutical company specialising in developing novel antibiotics, has granted a total of 1,500,000 options to…
Ablynx has issued additional 154,342 common shares in exchange for EUR1,011,939.05 as the result of the exercise of warrants.
Erytech Pharma’s new data supporting the second company’s product candidate ERY-MET will be presented at the 2017 Gastrointestinal Cancers Symposium…
The European Commission has cleared Sanofi’s Suliqua in combination with metformin, type 2 diabetes treatment, for European adult patients.
Danish biopharmaceutical company, Forward Pharma, has entered a deal with Biogen and certain other parties, regarding a Settlement and License Agreement.
Becton, Dickinson’s (BD’s) new kits that provide an easier method to identify and quantify genetic information in individual cells for genomics-based research, have started selling.
Pharnext, a French biopharmaceutical company focused on drugs against neurodegenerative diseases, has been named Best Life-Sciences IPO France 2016 Award.